TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 17 September 1, 2010
(The next issue will be on September 15, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1TyMfe4r978Jfx_w7gR2vGg/
Alkistis Frentzou G, Collier ME, Seymour AM, and Ettelaie C (2010) Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor. Mol Cell Biochem
http://www.ncbi.nlm.nih.gov/pubmed/20730477
Basavaraj MG, Gruber FX, Sovershaev M, Appelbom HI, Osterud B, Petersen LC, and Hansen JB (2010) The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20723970
Breyne J, Juthier F, Corseaux D, Marechaux S, Zawadzki C, et al. (2010) Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis
http://www.ncbi.nlm.nih.gov/pubmed/20732681
Del Fiorentino A, Cianchetti S, Celi A, and Pedrinelli R (2010) Aliskiren, a renin inhibitor, downregulates TNF-{alpha}-induced tissue factor expression in HUVECS. J Renin Angiotensin Aldosterone Syst
http://www.ncbi.nlm.nih.gov/pubmed/20798130
Demetz G, Seitz I, Stein A, Steppich B, Groha P, Brandl R, Schomig A, and Ott I (2010) Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. Atherosclerosis
http://www.ncbi.nlm.nih.gov/pubmed/20708733
Evangelho JS, Casali KR, Campos C, De Angelis K, Veiga AB, and Rigatto K (2010) Hypercholesterolemia magnitude increases sympathetic modulation and coagulation in LDLr knockout mice. Auton Neurosci
http://www.ncbi.nlm.nih.gov/pubmed/20719578
Garcia Rodriguez P, Eikenboom HC, Tesselaar ME, Huisman MV, Nijkeuter M, Osanto S, and Bertina RM (2010) Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20708219
Geiger A, Collange O, Samin J, Meyer A, Freys G, and Pottecher T (2010) [Efficiency and safety of recombinant activated factor VII in a case of severe postpartum hemorrhage.]. Ann Fr Anesth Reanim
http://www.ncbi.nlm.nih.gov/pubmed/20729029
Girolami A, Berti de Marinis G, and Bonamigo E (2010) Diagnosis of FVII Padua (Arg304Gln) by means of simple clotting tests. Clin Chim Acta
http://www.ncbi.nlm.nih.gov/pubmed/20713035
Gissel M, Undas A, Slowik A, Mann KG, and Brummel-Ziedins KE (2010) Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20709367
Ken-Dror G, Drenos F, Humphries E, Talmud PJ, Hingorani AD, Kivimaki M, Kumari M, Bauer KA, Morrissey JH, and Ireland HA (2010) Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20735728
Mahon KP, Love KT, Whitehead KA, Qin J, Akinc A, Leshchiner E, Leshchiner I, Langer R, and Anderson DG (2010) Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery. Bioconjug Chem 21:1448-1454.
http://www.ncbi.nlm.nih.gov/pubmed/20715849
McEachron TA, Pawlinski R, Richards KL, Church FC, and Mackman N (2010) Protease-activated receptors mediate cross-talk between coagulation and fibrinolysis. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20736455
Miller MA, Kandala NB, Kumari M, Marmot MG, and Cappuccio FP (2010) BAS/BSCR53 Relationships between sleep duration and von Willebrand factor, fibrinogen and factor VII: Whitehall II study. Heart 96:e28
http://www.ncbi.nlm.nih.gov/pubmed/20801846
Mita A, Ricordi C, Messinger S, Miki A, Misawa R, et al. (2010) Anti-proinflammatory effects of Iodixanol (OptiPrep)-based density gradient purification on human islet preparations. Cell Transplant
http://www.ncbi.nlm.nih.gov/pubmed/20719078
Mitra B, Phillips L, Cameron PA, Billah B, and Reid C (2010) The safety of recombinant factor VIIa in cardiac surgery. Anaesth Intensive Care 38:671-677.
http://www.ncbi.nlm.nih.gov/pubmed/20715730
Poller L, Ibrahim S, Keown M, Pattison A, and Jespersen J (2010) Simplified method for International Normalized Ratio (INR) derivation based on the Prothrombin Time/INR line: An international study. Clin Chem
http://www.ncbi.nlm.nih.gov/pubmed/20798354
Smith SA, McMichael M, Galligan A, Gilor S, and Hoh CM (2010) Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis
http://www.ncbi.nlm.nih.gov/pubmed/20739876
Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, and Morrissey JH (2010) Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20709905
Soeda T, Nogami K, Matsumoto T, Ogiwara K, and Shima M (2010) Mechanisms of factor VIIa-catalyzed activation of factor VIII. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20735721
Sorour Y, van Veen JJ, and Makris M (2010) Recombinant factor VIIa for unlicensed indications - a definite No or a cautious Maybe in selected patients? Int J Clin Pract
http://www.ncbi.nlm.nih.gov/pubmed/20722768
van Zaane B, Nur E, Squizzato A, Gerdes VE, Buller HR, Dekkers OM, and Brandjes DP (2010) Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20735729
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
